Heart medication shows potential for preventing/treating COVID-19
A team of investigators from Texas A&M University and The University of Texas Medical Branch (UTMB) report that an FDA-approved heart medication shows significant effectiveness in interfering with the entry of SARS-CoV-2 into human cells.
Read more about this study and the latest in COVID-19 research in The Week in COVID-19 Research — February 21–27, 2021.
